[Use of local magnitothermia in the treatment of patients with primary-confined skin melanoma].

Autor: Korovin SI, Tolstopiatov BA, Medinets IuR, Protsenko VV, Dedkov AG, Palivets AIu, Smakova MS
Jazyk: ruština
Zdroj: Likars'ka sprava [Lik Sprava] 2002 (1), pp. 129-33.
Abstrakt: We studied modifying potentialities of high temperatures in treatment regimens with adjuvant endolymphatic chemo- and interferontherapy of malignant melanoma of the skin. We had previously obtained enough evidence for expediency of adjuvant endolymphatic therapy of primary-localized melanoblastoma of the skin. Added to the preventive treatment regimens were sessions of local magnetothermia. The study was done in patients diagnosed as having primary-localized melanoma of the skin T(2-4) No Mo. A 3-year recurrence-free survival in the control group was (38.2 +/- 1.6)%, in the first study group--(54.2 +/- 5.8)%, in the second study group--(44.3 +/- 13.5)%. The general 3-year survival in the control group was (67.7 +/- 1.5)%, in the first study group--(70.8 +/- 5.5)%, in the second one--(91.7 +/- 5.7)%. In this way, the expediency has been proved of employment of local magnetothermia in treatment regimens to deal with malignant melanoma of the skin.
Databáze: MEDLINE